Elanco Animal Health Incorporated Property, Plant and Equipment, Gross
Elanco Animal Health Incorporated (ELAN) had Property, Plant and Equipment, Gross of $1.85 billion as of 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2025-02-25
- 2024-12-31: Property, Plant and Equipment, Gross $1.85B.
- 2023-12-31: Property, Plant and Equipment, Gross $1.84B.
- 2022-12-31: Property, Plant and Equipment, Gross $1.72B.
- 2021-12-31: Property, Plant and Equipment, Gross $2.10B.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2024-12-31 | $1.85B 10-K · filed 2025-02-25 |
| 2023-12-31 | $1.84B 10-K · filed 2025-02-25 |
| 2022-12-31 | $1.72B 10-K · filed 2024-02-26 |
| 2021-12-31 | $2.10B 10-K · filed 2023-03-01 |
| 2018-12-31 | $1.80B 10-K · filed 2020-02-28 |
| 2017-12-31 | $1.75B 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |